Phillip B. Storm, MD

Dr. Storm is an internationally recognized pediatric neurosurgeon specializing in brain and spine tumors, with particular expertise in endoscopic skull base surgery. As Chief of the Division of Neurosurgery at the Children's Hospital of Philadelphia (CHOP) and Director of the Center for Data Driven Discovery in Biomedicine (D3b), he has pioneered groundbreaking advances in surgical techniques, translational research, and precision medicine.

Dr. Storm’s clinical focus spans the treatment of all pediatric brain tumors, including low-grade gliomas, medulloblastomas, atypical teratoid rhabdoid tumors (AT/RT), and skull base tumors such as acoustic neuromas, craniopharyngiomas, and large cerebellopontine angle ependymomas. Recognizing the need for less invasive surgical options, he partnered with Penn Rhinologists to establish CHOP’s Endonasal Skull Base Program, which has since become the leading pediatric program of its kind. His work in endoscopic skull base surgery extends to the youngest patients, having successfully performed endonasal procedures on infants as young as three months old. His research has demonstrated that minimally invasive endonasal approaches can achieve complete tumor resection with reduced surgical morbidity, improving outcomes for children with craniopharyngiomas and other challenging skull base tumors. 

Beyond surgery, Dr. Storm has transformed the landscape of pediatric brain tumor research with his longtime friend and D3b co-founder and Director, Adam Resnick, Ph.D. As Directors of D3b, they have spearheaded efforts to integrate genomics, proteomics, and large-scale data platforms to develop more effective, targeted therapies. They also launched CAVATICA, a cloud-based biomedical data analysis platform supporting collaborative research in pediatric oncology. 

Dr. Storm built infrastructure ensuring that every tumor resected at CHOP undergoes molecular profiling to guide personalized treatment. A key partnership to accelerating advances in pediatric neuro-oncology is with the Children’s Brain Tumor Network (CBTN). The CBTN is an international consortium dedicated to real-time, open-data sharing and D3b is the coordinating center for the CBTN. This partnership has built one of the most comprehensive tumor biobanking and sequencing initiatives in the world.

Under Dr. Storm’s leadership, CHOP Neurosurgery has grown into one of the highest-volume pediatric neurosurgery programs in the nation, integrating cutting-edge clinical and research programs. Through these initiatives, CHOP Neurosurgery has secured over $150 million in NIH funding and philanthropic support, advancing both pediatric and adult brain tumor research.

Dr. Storm’s leadership is best stated in his own words, “My team and I are deeply committed to innovation and collaboration to shape the future of neurosurgery by advancing curative treatments for pediatric brain tumors, with the ultimate goal of putting me out of the tumor business.”